CIRB Studies

Below is the current list of studies covered by the CIRB. Participants should refer to ClinicalTrials.gov for general information about clinical trials. Institutions should refer to the Clinical Trials Support Unit (CTSU) website  for enrollment requirements and accrual status information. 

Study documents approved after July 1, 2013 are available to participating institutions for covered studies on the CTSU website. To request documents approved before July 1, 2013, participating institutions can contact the CIRB Helpdesk.

Review CIRB
Study Number Sort descending Network Study Title CIRB
ACCL10P1 COG Computerized Cognitive Training for Pediatric Brain Tumor Patients: A Pilot Study Pediatric CIRB
ACCL1131 COG A Phase III Open-Label Trial of Caspofungin vs. Azole Prophylaxis for Patients at High-Risk for Invasive Fungal Infections (IFI) Following Allogeneic Hematopoietic Cell Transplantation (HCT) Pediatric CIRB
ACCL15N1CD COG Use of Evidence-Based Supportive Care Clinical Practice Guidelines in Pediatric Oncology Pediatric CIRB
ACCL1633 COG The Effectiveness of Lactobacillus plantarum (LBP, IND #17339) In preventing Acute Graft-versus-Host Disease (GvHD) in Children undergoing Alternative Hematopoietic Progenitor Cell Transplantation (HCT) Pediatric CIRB
ACCL16N1CD COG Documentation and Delivery of Guideline-Consistent Treatment in Adolescent and Young Adult (AYA) Acute Lymphoblastic Leukemia (ALL) Pediatric CIRB
ACCL1931 COG A Randomized Trial of Levocarnitine Prophylaxis to Prevent Asparaginase-Associated Hepatotoxicity in Adolescents and Young Adults Receiving Acute Lymphoblastic Leukemia Therapy Pediatric CIRB
ACCL1932 COG Letermovir Prophylaxis for Cytomegalovirus in Pediatric Hematopoietic Cell Transplantation Pediatric CIRB
ACCL2031 COG A Phase 3 Randomized, Placebo-Controlled Trial Evaluating Memantine for Neurocognitive Protection in Children Undergoing Cranial Radiotherapy as Part of Treatment for Primary Central Nervous System Tumors Pediatric CIRB
ACCL20N1CD COG Financial Distress during Treatment for Pediatric Acute Lymphoblastic Leukemia in the United States Pediatric CIRB
ACCL21C2 COG Prospective Cohort Study to Evaluate Immunologic Response Following COVID-19 Vaccination in Children, Adolescents and Young Adults with Cancer Pediatric CIRB